JP2018172391A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018172391A5 JP2018172391A5 JP2018106308A JP2018106308A JP2018172391A5 JP 2018172391 A5 JP2018172391 A5 JP 2018172391A5 JP 2018106308 A JP2018106308 A JP 2018106308A JP 2018106308 A JP2018106308 A JP 2018106308A JP 2018172391 A5 JP2018172391 A5 JP 2018172391A5
- Authority
- JP
- Japan
- Prior art keywords
- factor
- peptide
- protein
- fab
- hormone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2013-0104112 | 2013-08-30 | ||
| KR20130104112 | 2013-08-30 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538860A Division JP6422977B2 (ja) | 2013-08-30 | 2014-08-29 | 抗血清アルブミンｆａｂエフェクター部分融合コンストラクト、およびその製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018172391A JP2018172391A (ja) | 2018-11-08 |
| JP2018172391A5 true JP2018172391A5 (https=) | 2019-02-14 |
| JP6800180B2 JP6800180B2 (ja) | 2020-12-16 |
Family
ID=52586989
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538860A Active JP6422977B2 (ja) | 2013-08-30 | 2014-08-29 | 抗血清アルブミンｆａｂエフェクター部分融合コンストラクト、およびその製造方法 |
| JP2018106308A Active JP6800180B2 (ja) | 2013-08-30 | 2018-06-01 | 抗血清アルブミンｆａｂエフェクター部分融合コンストラクト、およびその製造方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016538860A Active JP6422977B2 (ja) | 2013-08-30 | 2014-08-29 | 抗血清アルブミンｆａｂエフェクター部分融合コンストラクト、およびその製造方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9879077B2 (https=) |
| EP (2) | EP3039038B1 (https=) |
| JP (2) | JP6422977B2 (https=) |
| KR (2) | KR101576561B1 (https=) |
| CN (1) | CN105899532B (https=) |
| AU (1) | AU2014312456B2 (https=) |
| BR (1) | BR112016004355A2 (https=) |
| CA (1) | CA2922618C (https=) |
| DK (1) | DK3039038T3 (https=) |
| ES (1) | ES2866848T3 (https=) |
| MX (1) | MX371328B (https=) |
| PH (1) | PH12016500403A1 (https=) |
| PL (1) | PL3039038T3 (https=) |
| RU (1) | RU2661087C2 (https=) |
| UA (1) | UA117493C2 (https=) |
| WO (1) | WO2015030539A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108623691B (zh) * | 2017-03-17 | 2020-05-15 | 北京比洋生物技术有限公司 | IgG样长效免疫融合蛋白及其应用 |
| EP3806889A4 (en) * | 2018-06-18 | 2022-07-13 | Anwita Biosciences, Inc. | CYTOKI FUSION PROTEINS AND USES THEREOF |
| CN113710229B (zh) | 2019-02-25 | 2026-01-06 | 芝加哥大学 | 用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物 |
| KR20210095781A (ko) * | 2020-01-24 | 2021-08-03 | 주식회사 에이프릴바이오 | 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물 |
| KR102485892B1 (ko) * | 2020-04-09 | 2023-01-09 | 주식회사 에이프릴바이오 | 고양이 과립구 집락 자극인자 및 혈청 알부민에 대한 항원 결합 단편을 포함하는 융합 단백질 및 이의 용도 |
| KR20220044057A (ko) * | 2020-09-29 | 2022-04-06 | 주식회사 에이프릴바이오 | 인터루킨-18 결합 단백질 및 혈청 알부민에 대한 항원 결합 단편을 포함하는 융합 단백질, 및 이의 용도 |
| CN119343367A (zh) * | 2022-06-15 | 2025-01-21 | Ucb生物制药有限责任公司 | 卵泡抑素融合蛋白 |
| KR20240048577A (ko) * | 2022-10-04 | 2024-04-16 | 주식회사 에이프릴바이오 | 난포자극 호르몬 및 혈청 알부민에 대한 항원 결합 단편을 포함하는 융합 단백질 및 이의 용도 |
| WO2025253161A1 (en) * | 2024-06-05 | 2025-12-11 | Aprilbio Co., Ltd. | Methods for treating liver diseases using recombinant fusion proteins comprising interleukin-18-binding protein and antigen binding fragment to serum albumin |
| CN118393137B (zh) * | 2024-07-01 | 2024-08-20 | 广东赛尔生物科技有限公司 | 一种肠道保护菌的检测试剂盒及其应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW517061B (en) * | 1996-03-29 | 2003-01-11 | Pharmacia & Amp Upjohn Ab | Modified/chimeric superantigens and their use |
| AU2003244817B2 (en) * | 2002-06-28 | 2010-08-26 | Domantis Limited | Antigen-binding immunoglobulin single variable domains and dual-specific constructs |
| US9321832B2 (en) * | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
| GB0315450D0 (en) * | 2003-07-01 | 2003-08-06 | Celltech R&D Ltd | Biological products |
| CN101031588A (zh) * | 2004-06-01 | 2007-09-05 | 多曼蒂斯有限公司 | 药物组合物，融合物和结合物 |
| TW200607523A (en) * | 2004-06-01 | 2006-03-01 | Domantis Ltd | Drug compositions, fusions and conjugates |
| AU2005334481A1 (en) * | 2004-08-11 | 2007-01-25 | Trubion Pharmaceuticals, Inc. | Binding domain fusion proteins |
| MX2007003907A (es) * | 2004-10-05 | 2007-05-21 | Genentech Inc | Agentes terapeuticos con toxicidad reducida. |
| RU2411957C2 (ru) | 2004-12-02 | 2011-02-20 | Домантис Лимитед | Способы лечения респираторного заболевания с применением антагонистов рецептора интерлейкина-1 типа 1 |
| JP5142707B2 (ja) * | 2005-02-08 | 2013-02-13 | 一般財団法人化学及血清療法研究所 | 抗体の改良方法 |
| AU2008261042A1 (en) * | 2007-06-08 | 2008-12-11 | Dow Global Technologies Inc. | Expression of soluble antibody fragment by truncation of CH1 domain |
| EP2535349A1 (en) * | 2007-09-26 | 2012-12-19 | UCB Pharma S.A. | Dual specificity antibody fusions |
| MX2010011145A (es) * | 2008-04-11 | 2011-04-11 | Merrimack Pharmaceuticals Inc | Enlazadores de la albumina de suero humana y conjugados de la misma. |
| CA2737241C (en) * | 2008-09-26 | 2017-08-29 | Ucb Pharma S.A. | Multivalent antibody fusion proteins |
| EP2364326B1 (en) * | 2008-12-05 | 2018-07-04 | Glaxo Group Limited | Methods for selecting protease resistant polypeptides |
| WO2011015649A1 (en) * | 2009-08-06 | 2011-02-10 | Novo Nordisk Health Care Ag | Growth hormones with prolonged in-vivo efficacy |
| GB201005063D0 (en) * | 2010-03-25 | 2010-05-12 | Ucb Pharma Sa | Biological products |
| CN104147611A (zh) * | 2009-09-30 | 2014-11-19 | 葛兰素集团有限公司 | 具有延长的半衰期的药物融合体和缀合物 |
| WO2012158818A2 (en) * | 2011-05-16 | 2012-11-22 | Fabion Pharmaceuticals, Inc. | Multi-specific fab fusion proteins and methods of use |
| WO2013068571A1 (en) * | 2011-11-11 | 2013-05-16 | Ucb Pharma S.A. | Albumin binding antibodies and binding fragments thereof |
-
2014
- 2014-08-29 BR BR112016004355A patent/BR112016004355A2/pt not_active Application Discontinuation
- 2014-08-29 CA CA2922618A patent/CA2922618C/en active Active
- 2014-08-29 CN CN201480056265.1A patent/CN105899532B/zh active Active
- 2014-08-29 UA UAA201601685A patent/UA117493C2/uk unknown
- 2014-08-29 WO PCT/KR2014/008106 patent/WO2015030539A1/en not_active Ceased
- 2014-08-29 RU RU2016105586A patent/RU2661087C2/ru active
- 2014-08-29 DK DK14839630.2T patent/DK3039038T3/da active
- 2014-08-29 AU AU2014312456A patent/AU2014312456B2/en active Active
- 2014-08-29 EP EP14839630.2A patent/EP3039038B1/en active Active
- 2014-08-29 PL PL14839630T patent/PL3039038T3/pl unknown
- 2014-08-29 EP EP19192902.5A patent/EP3632930A1/en not_active Withdrawn
- 2014-08-29 JP JP2016538860A patent/JP6422977B2/ja active Active
- 2014-08-29 MX MX2016002539A patent/MX371328B/es active IP Right Grant
- 2014-08-29 ES ES14839630T patent/ES2866848T3/es active Active
- 2014-09-01 KR KR1020140115673A patent/KR101576561B1/ko active Active
-
2015
- 2015-09-25 KR KR1020150136164A patent/KR20150118565A/ko not_active Ceased
-
2016
- 2016-02-29 PH PH12016500403A patent/PH12016500403A1/en unknown
- 2016-02-29 US US15/056,299 patent/US9879077B2/en active Active
-
2017
- 2017-09-27 US US15/717,528 patent/US10618953B2/en active Active
-
2018
- 2018-06-01 JP JP2018106308A patent/JP6800180B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018172391A5 (https=) | ||
| RU2016105586A (ru) | Гибридная конструкция, включающая антигенсвязывающий фрагмент, специфичный к сывороточному альбумину и эффекторный компонент, и способы ее получения | |
| JP6689329B2 (ja) | 免疫グロブリンＦｃ変異体 | |
| KR101200659B1 (ko) | 세 말단 반응기를 갖는 비펩타이드성 중합체를 이용한 생리활성 폴리펩타이드 약물 결합체 | |
| AU2005311099B2 (en) | Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY | |
| CA2512933A1 (en) | A pharmaceutical composition comprising an immunoglobulin fc region as a carrier | |
| Kontermann | Strategies for extended serum half-life of protein therapeutics | |
| ES2623925T3 (es) | Proteínas de fusión de inmunoglobulina | |
| JP2020023520A (ja) | コイルドコイルの免疫グロブリン融合タンパク質およびその組成物 | |
| CN106661128A (zh) | 构建氨基末端免疫球蛋白融合蛋白的方法及其组合物 | |
| JP2007537992A5 (https=) | ||
| JP2007536211A5 (https=) | ||
| JP2021525807A5 (https=) | ||
| TH2201000302A (th) | วิธีการใหม่สำหรับการเตรียมคอนจูเกตยาที่ออกฤทธิ์ยาวนานโดยการเตรียมตัวกลาง |